Retina Group of New York to Provide Diabetic Retinopathy Education at Tour de Cure and Step Out Walk to Stop Diabetes Fundraiser
(PRWEB) August 25, 2017 -- The Retina Group of New York (RGONY) is pleased to participate in the 2017 Greater New York BoardWALK Festival and Tour de Cure American Diabetes Association fundraiser on September 24. Nearly 2,000 attendees are anticipated to walk, run, and ride including 200 Red Striders/Runners and 100 Teams. Other sponsors include Novo Nordisk, Walgreens/Duane Reade, and MSTANY.
The BoardWALK Festival and Tour de Cure event will encompass features of an enhanced event that aligns with the American Diabetes Association’s new strategic plan. While the event will continue to showcase the signature Step Out Walk to Stop Diabetes, new components will include a Tour de Cure and Bootcamp Obstacle Course Challenge. The Bootcamp Obstacle Course will have rotating classes throughout the day; two designed for adults and one special kids/youth Bootcamp session. There will be a 5k Boardwalk Run and multiple cycling courses available to participants. In addition, the day will also include a ‘Living Active” area, Live Cooking/Healthy Eating demonstrations and sampling, a Health and Wellness Festival Pavilion, and on-site health screenings. The day will be suited for all ages, and encompass a complete overall Health and Well-Being Festival feel.
James M. Maisel, MD, RGONY Chairman, retinal specialist, and recipient of the Juvenile Diabetes Research Foundation Humanitarian of the Year award 2017, states, “Diabetic retinopathy can be asymptomatic, so it is important for community members with diabetes to get a yearly dilated eye exam. Sharp vision can be maintained with medications and laser has prevented almost all diabetic related blindness since the 1970s. More advanced disease can often regain vision with brief outpatient surgery.”
Event enhancements will include a Military Style Boot Camp Challenge, 5k Boardwalk Run/Walk, Cycling Routes, Live Cooking Demonstrations, ‘Get Fit, Don’t Sit’ Area, Health Pavilion EXPO, on-site Health Screenings, Team Tents, Red Strider/Runner Clubhouse, Champions/VIP Tent, and Live Music.
Location and schedule:
Jones Beach, Field 5, 1 Ocean Pkwy, Wantagh, NY 11793
Check In begins: 8:00 am
40 mile bike ride begins 9:00am
5k Run Begins: 9:30 amWalk Begins: 10:00 am
10 mile bike ride begins at 10:30am
Boot Camp Challenge Courses throughout the day
Event information and registration:
Visit http://www.diabetes.org/gny or contact Nicole Hartner, Associate Director, Greater New York American Diabetes Association Tour de Cure, 631.348.0422, ext. 3572
About Retina Group of New York (RGONY)
Dr. James M. Maisel is the Founder and Chairman of the Retina Group of New York, USA. He is a Board Certified ophthalmologist who completed his Dyson Fellowship in vitreous and retinal surgery at New York-Presbyterian/Weill Cornell Medical Center. He was honored as the 2017 Humanitarian of the Year by the Juvenile Diabetes Research Foundation and was chairman of the Epidemiology and Prevention of Diabetes Section at the 5th World Congress of Diabetes 2017. He has served as a Corporate Advisory Board member for the Foundation of the American Academy of Ophthalmology (AAO) and the Juvenile Diabetes Foundation Medical Advisory Board. He was also a member of the AAO Instrument and Device and Low Vision Committees and has received research grants from the U.S. Public Health Service and the National Institute of Health. Dr. Maisel represented the National Society to Prevent Blindness at the ANSI Z-80 committee where he helped establish many ophthalmic industry standards. He served as an editor of EyeCare Technology Magazine and Diabetes Technology Magazine, authored numerous professional journal articles, and lectures nationally on retina, medical informatics and practice management topics. Dr. Maisel is also the Chairman of ZyDoc, a medical informatics and transcription company whose MediSapien software was ranked as one of the top five applications in The Data Design Diabetes Sanofi US Innovation Challenge. In addition, he has been a clinical investigator, consultant, educator, and advisory board member for Pfizer, Novartis, EyeTech, TopCon, Genentech, Alimera, Regeneron and Allergan.
The Retina Group of New York board certified retina specialists have provided tertiary vitreoretinal care to patients in Nassau and Suffolk Counties since 1986 at RGONY offices in Hicksville and Hauppauge. Both locations are fully equipped with in-office laser capabilities, cutting-edge diagnostic equipment, and integrated electronic records. The group holds staff privileges at eight area hospitals and teaching appointments at the Hofstra Northwell School of Medicine, North Shore University Hospital, and NuHealth Nassau University Medical Center. The practice is limited to medical and surgical retinal problems. These commonly include diabetic retinopathy, macular degeneration, retinal vein occlusion, retinal detachment, macular pucker, macula hole, surgery complications, uveitis, Plaquenil toxicity and second opinions. For more information on The Retina Group of New York, visit http://www.rgony.com or call 516-939-6100.
James M. Maisel, MD, ZyDoc, http://www.rgony.com, +1 (516) 939-6100, [email protected]
Share this article